Online GLP-1 Programs in Tennessee
Tennessee carries one of the country's heaviest obesity burdens, and in a move against the national trend, its TennCare program added coverage of weight-loss GLP-1s in 2025. Because Tennessee did not expand Medicaid, though, that benefit reaches a narrower group than it would elsewhere.
Population
7.1M
15th-largest state
Adult obesity
37.6%
2024 BRFSS
Diagnosed diabetes
14.5%
2024 BRFSS
Medicaid (weight loss)
CoveredFrom $129/mo · Ships in 2–4 days · Sponsored
Insurance
Does Tennessee Medicaid cover GLP-1s?
TennCare added coverage of FDA-approved obesity medications, including GLP-1s like Wegovy and Zepbound, for members 21 and older effective August 1, 2025, with prior authorization and quantity limits (Obesity Action Coalition, 2025). That made Tennessee one of the few states adding coverage while others cut it. The catch: Tennessee did not expand Medicaid, so many low-income adults do not qualify for TennCare at all. GLP-1s for type 2 diabetes are covered, as federal law requires.
Online Access
Getting a GLP-1 online in Tennessee
GLP-1s are not controlled substances, so Tennessee allows them to be prescribed via telehealth when a Tennessee-licensed clinician establishes a valid patient relationship and meets the standard of care (Tennessee telehealth rules, 2026). Online programs can serve residents statewide through a Tennessee-licensed prescriber.
Compounding
Compounded semaglutide & tirzepatide in Tennessee
Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Tennessee adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.
Demand
Where GLP-1 demand is highest in Tennessee
Nearly 38% of Tennessee adults have obesity and about 14% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024), among the highest burdens in the nation. Demand centers on Nashville and Memphis. TennCare's 2025 decision to cover weight-loss GLP-1s gives qualifying residents a public-payer path, though the state's non-expansion status limits who can use it.
Questions
Tennessee GLP-1 FAQ
Does TennCare cover Wegovy or Zepbound?
Yes, since August 1, 2025, for members 21 and older with prior authorization and quantity limits (Obesity Action Coalition, 2025). Because Tennessee did not expand Medicaid, though, many low-income adults do not qualify for TennCare in the first place.
Can I get a GLP-1 prescribed online in Tennessee?
Yes, by a Tennessee-licensed clinician. GLP-1s are not controlled substances, so standard telehealth standard-of-care rules apply.
Why is access still limited if TennCare covers it?
Tennessee did not expand Medicaid, so non-disabled childless adults generally don't qualify for TennCare at all, leaving many residents in the coverage gap despite the new benefit (KFF, 2026).
Compound Guides
The GLP-1s behind these programs
Sources
How we sourced this page
Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.
- 1.Obesity Action Coalition — TennCare expands coverage for obesity medications (2025)
- 2.The RX Index — Medicaid GLP-1 coverage by state (2026)
- 3.KFF — Status of State Medicaid Expansion Decisions (2026)
- 4.America's Health Rankings — Tennessee obesity (CDC BRFSS 2024)
- 5.KFF — Medicaid Coverage of and Spending on GLP-1s (Jan 2026)
- 6.FDA — Compounding policy as GLP-1 supply stabilizes (2025)
Telehealth, no insurance needed
Personalized GLP-1 for Tennessee residents
Skip the coverage maze. Yucca Health connects Tennessee residents with US-licensed clinicians for personalized GLP-1 treatment, from $129/mo.
See if you qualifySponsored · Affiliate disclosure
Educational information only, not medical or legal advice and not a substitute for a licensed clinician. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state before starting treatment. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.